Potential COVID-19 Vaccine From Cannabis Components

In Canada, experienced researchers focused in the line of infectious disease, are experimenting with the possible use of components found in cannabis, as they work hard at finding a vaccine for the novel coronavirus that causes COVID-19. The research team at the University of Saskatchewan in Canada, believe a plant-based antigen is a more viable option in a search for vaccine than animal-based antigen.

CANNABIS COMPONENTS POTENTIAL COVID-19 VACCINE

Researchers believe that the plant-based compounds will be a faster remedy due to the ability of plant-based components swiftly cloning proteins. The idea is that if a plant-based vaccine is discovered, then it will be faster to produce on a large scale for commercial availability.

The research team Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) partnered with the medical cannabis company Zyus Life Sciences to test the use of plant-based components from cannabis in producing a protein that can be used as a COVID-19 vaccine. As researchers across the globe race to find a vaccine, it can be seen that researches testing all available optionsin the hopes of finding a safe and effective vaccine against the novel coronavirus (COVID-19).